Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant
Sign Up to like & getrecommendations! Published in 2020 at "Nature Communications"
DOI: 10.1038/s41467-020-16805-5
Abstract: Multiple myeloma (MM) is a plasma-cell neoplasm that is treated with high-dose chemotherapy, autologous stem cell transplant (ASCT) and long-term immunomodulatory drug (IMiD) maintenance. The presence of somatic mutations in the peripheral blood is termed… read more here.
Keywords: multiple myeloma; imid maintenance; adverse outcomes; associated adverse ... See more keywords